40
1 Cox Regression II Kristin Sainani Ph.D. http://www.stanford.edu/~kcobb Stanford University Department of Health Research and Policy

1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

Embed Size (px)

Citation preview

Page 1: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

1

Cox Regression II

Kristin Sainani Ph.D.http://www.stanford.edu/~kcobbStanford UniversityDepartment of Health Research and Policy

Page 2: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

2

Topics Stratification Age as time scale Residuals Repeated events Intention-to-treat analysis for RCTs

Page 3: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

3

1. Stratification

Violations of PH assumption can be resolved by:•Adding time*covariate interaction

•Adding other time-dependent version of the covariate

•Stratification

Page 4: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

4

Stratification

•Different stratum are allowed to have different baseline hazard functions.

•Hazard functions do not need to be parallel between different stratum.

•Essentially results in a “weighted” hazard ratio being estimated: weighted over the different strata.

•Useful for “nuisance” confounders (where you do not care to estimate the effect).

•Does not allow you to evaluate interaction or confounding of stratification variable (will miss possible interactions).

Page 5: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

5

Males: 1, 3, 4, 10+, 12, 18 (subjects 1-6) Females: 1, 4, 5, 9+ (subjects 7-10)

Example: stratify on gender

)....)5()5(

)5((

))1()4()4(

)4(()

)4()4()4()4(

)4(()

)3()3()3()3()3(

)3((

))1()1()1()1(

)1(()

)1()1()1()1()1()1(

)1(()(

109

1098

8

6543

3

65432

2

10987

7

654321

1

1

hh

hx

hhh

hx

hhhh

hx

hhhhh

h

hhhh

hx

hhhhhh

hLL

m

iip

β

♂♀ ♀

Page 6: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

6

The PL

....

))1()1()1()1(

)1((

))1()1()1()1()1()1(

)1((

)(

10987

7

654321

1

0000

0

000000

0

1

βxβxβxβx

βx

βxβxβxβxβxβx

βx

β

eeee

e

xeeeee

et

LL

ffff

f

mmmmmm

m

m

iip

)...()()(10987

7

654321

1

1βxβxβxβx

βx

βxβxβxβxβxβx

βx

βeeee

ex

eeeee

eLL

m

iip

Page 7: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

7

Age is a common confounder in Cox Regression, since age is strongly related to death and disease.

You may control for age by adding baseline age as a covariate to the Cox model.

A better strategy for large-scale longitudinal surveys, such as NHANES, is to use age as your time-scale (rather than time-in-study).

You may additionally stratify on birth cohort to control for cohort effects.

2. Using age as the time-scale in Cox Regression

Page 8: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

8

Age as time-scale The risk set becomes everyone who was

at risk at a certain age rather than at a certain event time.

The risk set contains everyone who was still event-free at the age of the person who had the event.

Requires enough people at risk at all ages (such as in a large-scale, longitudinal survey).

Page 9: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

9

The likelihood with age as time

Event times: 3, 5, 7+, 12, 13+ (years-in-study)

Baseline ages: 28, 25, 40, 29, 30 (years)

Age at event or censoring: 31, 30, 47+, 41, 43+

))41()41()41(

)41(()

)31()31()31(

)31((

))30()30()30()30(

)30(()(

543

4

541

1

5421

2

1

hhh

hx

hhh

h

xhhhh

hLL

m

iip

β

Page 10: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

10

3. Residuals Residuals are used to investigate

the lack of fit of a model to a given subject.

For Cox regression, there’s no easy analog to the usual “observed minus predicted” residual of linear regression

Page 11: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

11

Martingale residual ci (1 if event, 0 if censored) minus the estimated

cumulative hazard to ti (as a function of fitted model) for individual i:

ci-H(ti,Xi,ßi) E.g., for a subject who was censored at 2 months, and whose

predicted cumulative hazard to 2 months was 20% Martingale=0-.20 = -.20

E.g., for a subject who had an event at 13 months, and whose predicted cumulative hazard to 13 months was 50%:

Martingale=1-.50 = +.50

Gives excess failures. Martingale residuals are not symmetrically

distributed, even when the fitted model is correctly, so transform to deviance residuals...

Page 12: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

12

Deviance Residuals

The deviance residual is a normalized transform of the martingale residual. These residuals are much more symmetrically distributed about zero.

Observations with large deviance residuals are poorly predicted by the model.

Page 13: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

13

Deviance Residuals Behave like residuals from ordinary

linear regression Should be symmetrically distributed

around 0 and have standard deviation of 1.0.

Negative for observations with longer than expected observed survival times.

Plot deviance residuals against covariates to look for unusual patterns.

Page 14: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

14

Deviance Residuals In SAS, option on the output

statement:Output out=outdata resdev=Varname

**Cannot get diagnostics in SAS if time-dependent covariate in the model

Page 15: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

15

Example: uis data

Out of 628 observations, a few in the range of 3-SD is not unexpected

Pattern looks fairly symmetric around 0.

Page 16: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

16

Example: uis data

What do you think this cluster represents?

Page 17: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

17

Example: censored only

Page 18: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

18

Example: had event only

Page 19: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

19

Schoenfeld residuals Schoenfeld (1982) proposed the first set

of residuals for use with Cox regression packages Schoenfeld D. Residuals for the proportional

hazards regresssion model. Biometrika, 1982, 69(1):239-241.

Instead of a single residual for each individual, there is a separate residual for each individual for each covariate

Note: Schoenfeld residuals are not defined for censored individuals.

Page 20: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

20

Schoenfeld residuals The Schoenfeld residual is defined as the

covariate value for the individual that failed minus its expected value. (Yields residuals for each individual who failed, for each covariate).

Expected value of the covariate at time ti = a weighted-average of the covariate, weighted by the likelihood of failure for each individual in the risk set at ti.

)(

1

residualitRj

ijjkik pxx

person i for the nowevent ofy probabilit

(age)years 56.,.e

th

setrisk

1

jp

pgj

ij

The person who died was 56; based on the fitted model, how likely is it that the person who died was 56 rather than older?

Page 21: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

21

Example 5 people left in our risk set at

event time=7 months: Female 55-year old smoker Male 45-year old non-smoker Female 67-year old smoker Male 58-year old smoker Male 70-year old non-smoker

The 55-year old female smoker is the one who has the event…

Page 22: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

22

ExampleBased on our model, we can calculate a

predicted probability of death by time 7 for each person (call it “p-hat”):

Female 55-year old smoker: p-hat=.10 Male 45-year old non-smoker : p-hat=.05 Female 67-year old smoker : p-hat=.30 Male 58-year old smoker : p-hat=.20 Male 70-year old non-smoker : p-hat=.30

Thus, the expected value for the AGE of the person who failed is:

55(.10) + 45 (.05) + 67(.30) + 58 (.20) + 70 (.30)= 60And, the Schoenfeld residual is: 55-60 = -5

Page 23: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

23

ExampleBased on our model, we can calculate a

predicted probability of death by time 7 for each person (call it “p-hat”):

Female 55-year old smoker: p-hat=.10 Male 45-year old non-smoker : p-hat=.05 Female 67-year old smoker : p-hat=.30 Male 58-year old smoker : p-hat=.20 Male 70-year old non-smoker : p-hat=.30

The expected value for the GENDER of the person who failed is:

0(.10) + 1(.05) + 0(.30) + 1 (.20) + 1 (.30)= .55And, the Schoenfeld residual is: 0-.55 = -.55

Page 24: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

24

Schoenfeld residuals Since the Schoenfeld residuals are, in

principle, independent of time, a plot that shows a non-random pattern against time is evidence of violation of the PH assumption. Plot Schoenfeld residuals against time to

evaluate PH assumption Regress Schoenfeld residuals against time

to test for independence between residuals and time.

Page 25: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

25

Example: no pattern with time

Page 26: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

26

Example: violation of PH

Page 27: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

27

Schoenfeld residualsIn SAS: option on the output statement:Output out=outdata ressch= Covariate1

Covariate2 Covariate3

Page 28: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

28

Summary of the many ways to evaluate PH assumption…

1. Examine log(-log(S(t)) plotsPH assumption is supported by parallel lines and refuted by lines that cross or

nearly crossMust use categorical predictors or categories of a continuous predictor

2. Include interaction with time in the modelPH assumption is supported by non-significant interaction coefficient and refuted by

significant interaction coefficientRetaining the interaction term in the model corrects for the violation of PHDon’t complicate your model in this way unless it’s absolutely necessary!

3. Plot Schoenfeld residualsPH assumption is supported by a random pattern with time and refuted by a non-

random pattern

4. Regress Schoenfeld residuals against time to test for independence between residuals and time.

PH assumption is supported by a non-significant relationship between residuals and time, and refuted by a significant relationship

Page 29: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

29

Death (presumably) can only happen once, but many outcomes could happen twice… Fractures Heart attacks PregnancyEtc…

4. Repeated events

Page 30: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

30

Strategy 1: run a second Cox regression (among those who had a first event) starting with first event time as the origin

Repeat for third, fourth, fifth, events, etc. Problems: increasingly smaller and

smaller sample sizes.

Repeated events: 1

Page 31: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

31

Treat each interval as a distinct observation, such that someone who had 3 events, for example, gives 3 observations to the dataset Major problem: dependence between

the same individual

Repeated events: Strategy 2

Page 32: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

32

Stratify by individual (“fixed effects partial likelihood”)

In PROC PHREG: strata id; Problems: does not work well with RCT data requires that most individuals have at least 2

events Can only estimate coefficients for those

covariates that vary across successive spells for each individual; this excludes constant personal characteristics such as age, education, gender, ethnicity, genotype

Strategy 3

Page 33: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

33

5. Considerations when analyzing data from an RCT…

Page 34: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

34

Intention-to-Treat Analysis

Intention-to-treat analysis: compare outcomes according to the groups to which subjects were initially assigned, regardless of which intervention they actually received.

Evaluates treatment effectiveness rather than treatment efficacy

Page 35: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

35

Why intention to treat? Non-intention-to-treat analyses lose the

benefits of randomization, as the groups may no longer be balanced with regards to factors that influence the outcome.

Intention-to-treat analysis simulates “real life,” where patients often don’t adhere perfectly to treatment or may discontinue treatment altogether.

Page 36: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

36

Drop-ins and Drop-outs: example, WHI

Both women on placebo and women on active treatment discontinued study

medications.

Women on placebo “dropped in” to treatment because their regular doctors put

them on hormones (dogma= “hormones are good”).

Women on treatment “dropped in” to treatment because their doctors took them off study drugs and put them on hormones to

insure they were on hormones and not placebo.Women’s Health Initiative Writing Group. JAMA. 2002;288:321-333.

Page 37: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

37

Effect of Intention to treat on the statistical analysis Intention-to-treat analyses tend to

underestimate treatment effects; increased variability “waters down” results.

Page 38: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

38

ExampleTake the following hypothetical RCT:Treated subjects have a 25% chance of dying during the 2-

year study vs. placebo subjects have a 50% chance of dying.

TRUE RR= 25%/50% = .50 (treated have 50% less chance of dying)

You do a 2-yr RCT of 100 treated and 100 placebo subjects. If nobody switched, you would see about 25 deaths in the

treated group and about 50 deaths in the placebo group (give or take a few due to random chance).

Observed RR .50

Page 39: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

39

Example, continuedBUT, if early in the study, 25 treated subjects

switch to placebo and 25 placebo subjects switch to control.

You would see about 25*.25 + 75*.50 = 43-44 deaths in the placebo group

And about25*.50 + 75*.25 = 31 deaths in the treated group

Observed RR = 31/44 .70Diluted effect!

Page 40: 1 Cox Regression II Kristin Sainani Ph.D. kcobb Stanford University Department of Health Research and Policy kcobb

40

ReferencesPaul Allison. Survival Analysis Using SAS. SAS

Institute Inc., Cary, NC: 2003.